| Fetal MRI scans provide value when trying to learn more about congenital heart defects |
| FDA approves inclisiran, a twice-yearly injection that lowers cholesterol |
| Researchers take a fresh look at how different risk factors impact the look of a patient's heart |
| As healthcare leaders look ahead to 2022, preparation and planning are the keys to success |
| COVID-19 vaccines tied to greater risk of myocarditis or myopericarditis—but specialists highlight the benefits of vaccination |
| Premature heart attack deaths more common among Black, male and rural patients |
| Apixaban linked to lower bleeding risk than rivaroxaban for patients with nonvalvular AFib |
| An industry first: FDA authorizes marketing of laser-assisted IVC filter removal device |
| FDA approves rivaroxaban for treating, preventing blood clots in pediatric patients |
| Tafamidis boosts survival for patients with transthyretin amyloid cardiomyopathy |
| AECG monitoring helps identify when TAVR patients may require a permanent pacemaker |
| DOACs underprescribed among high-risk AFib patients |
| Cardiologists report an average 2021 salary of $538K, up 2% from 2020, as pandemic continues |
| Edwards gains FDA approval for new Sapien 3 solution for TPV replacement |
| Metoprolol demonstrates value as a treatment for obstructive hypertrophic cardiomyopathy |
| AI improves detection of severe CAD in stress echocardiograms |
| CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots |
| Cardiologist interviewed by Joe Rogan claims U.S. withheld early COVID-19 treatments to promote fear, push support for vaccines |
| Decades of data help researchers recommend the optimal HFrEF treatment |
| Heart transplants from adult donors after circulatory death yield positive outcomes |
| What happens when TAVR patients also require a peripheral vascular intervention |
| FDA announces Class I recall of intra-aortic balloon pumps after 1 death, 71 complaints |
| American Heart Association investing $10 million to study the long-term consequences of COVID-19 |
| Cardiovascular surgeon wants to sue hospital after he was fired for refusing COVID-19 vaccine |
| Medtronic receives warning letter from FDA after inspection, sees stock prices drop 7% |
| Cardiac imaging specialists receive more than $20M in new funding |
| How treatment decisions can impact young adults with PAD and advanced femoropopliteal disease |
| A key difference between stroke symptoms for men and women |
| Treating high blood pressure during pregnancy is safe and effective, new scientific statement confirms |
| Surgery journal appoints first female editor-in-chief |
| Senators to question cardiologist Robert Califf, Biden’s nominee to lead FDA, on industry ties and COVID-19 response |
| What new research tells us about HIV and heart failure |
| Heart attack survivors with kidney issues face a greater risk of heart failure |
| Cardiologists enthusiastic as House passes bill to ramp up valvular heart disease research |
| Prosthetic-patient mismatch after TAVR much less likely among Asian patients |
| Breathlessness among patients with long COVID may be a sign of heart damage |
| New ACC/AHA guidelines detail updated recommendations for PCI, CABG |
| Pre-TAVR pulmonary artery dilatation helps identify high-risk patients |
| Physicians could save $641M per year by prescribing generic CVD medications |
| Exposure to even small amounts of toxic metals increases the risk of clogged arteries |
| Cardiologist back at work after testing positive for Omicron COVID-19 variant |
| Cardiologists support legislation that would limit costly Medicare cuts |
| Catheter ablation 'significantly superior' to drug therapy when treating AFib |
| ‘Surprising’ trends in ICD use among HCM patients |
| Autopsies suggest we still have a lot to learn about COVID-19's impact on the heart |
| TTVR patients see consistent improvements in their daily lives |
| Researchers 'really enthusiastic' about potential breakthrough in the treatment of vascular disease |
| American Heart Association supports new ‘surprise billing’ legislation, but physician groups have serious doubts |
| TEVAR outcomes don't suffer when performed at low-volume hospitals |
| KCCQ-12 scores a valuable asset for managing patients with acute HF |
| AI model predicts patient survival after cardiac surgery |
| Pressure-regulated THV deployment could provide significant value |
| As Omicron variant spreads, American Heart Association highlights continued support of COVID-19 vaccination |
| What new valve-in-valve TAVR data tell us about valve durability |
| Most young people with vaccine-related myocarditis recover quickly |
| Predicting AFib recurrence after catheter ablation remains a challenge |
| SAVR a valuable treatment option for asymptomatic patients with severe AS |
| Elevated heart rate tied to a greater risk of dementia |
| Ultra-processed foods increase the risk of a repeat heart attack or stroke |
| Medicare spending on cardiology, interventional cardiology declined $906M in 2020 |
| 2 new studies confirm the ‘very low’ risk of myocarditis after COVID-19 vaccination |
| Predicting when T2D patients may experience a cardiovascular event |
| DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib |
| How major life events can take a toll on the heart |
| Cardiologist shares story after testing positive for Omicron COVID-19 variant—says he caught it during cardiology conference |
| SGLT2 inhibitors lower risk of HFpEF, new meta-analysis confirms |
| FDA announces Class I recall of percutaneous thrombolytic device after multiple complaints |
| Trying to anticipate major AFib events among HCM patients |
| New data on the link between COVID-19 vaccines and myopericarditis |
